09/23/2025 | Press release | Distributed by Public on 09/23/2025 15:23
Filed Pursuant to Rule 424(b)(2)
Registration Nos. 333-268718 and 333-268718-01
|
|||||
Pricing Supplement
Dated September 19, 2025
(To Prospectus dated December 30, 2022,
Series A Prospectus Supplement dated December 30, 2022 and
Product Supplement No. WF-1 dated March 8, 2023)
|
|||||
BofA Finance LLC
Medium-Term Notes, Series A
Fully and Unconditionally Guaranteed by Bank of America Corporation
|
|||||
Market Linked Securities-Auto-Callable with Contingent Downside
$1,507,000 Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
|||||
■ Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF (each referred to as an "Underlying")
■ Unlike ordinary debt securities, the Securities do not pay interest, do not repay a fixed amount of principal at maturity and are subject to potential automatic call upon the terms described below. Whether the Securities are automatically called for a fixed call premium or, if not automatically called, the maturity payment amount, will depend, in each case, on the closing value of the Lowest Performing Underlying on the relevant Call Date. The Lowest Performing Underlying on any Call Date is the Underlying that has the lowest closing value on that Call Date as a percentage of its Starting Value
■ Automatic Call. If the closing value of the Lowest Performing Underlying on any Call Date is greater than or equal to its Call Value, the Securities will be automatically called for the principal amount plus the Call Premium applicable to that Call Date. The Call Premium applicable to each Call Date is a percentage of the principal amount that increases for each Call Date based on a simple (non-compounding) return of approximately 12.00% per annum. The Call Value for each Underlying is 86% of its Starting Value. Please see "Terms of the Securities - Call Dates and Call Premiums" below for the Call Dates and Call Premiums
■ Maturity Payment Amount. If the Securities are not automatically called, you will receive a Maturity Payment Amount that could be equal to or less than the principal amount per Security depending on the closing value of the Lowest Performing Underlying on the Final Calculation Day as follows:
■
If the closing value of the Lowest Performing Underlying on the Final Calculation Day is less than its Call Value, but greater than or equal to its Threshold Value, you will receive the principal amount of your Securities
■
If the closing value of the Lowest Performing Underlying on the Final Calculation Day is less than its Threshold Value, you will have full downside exposure to the decrease in the value of the Lowest Performing Underlying from its Starting Value, and you will lose more than 40%, and possibly all, of the principal amount of your Securities.
■ The Threshold Value for each Underlying is 60% of its Starting Value
■ Investors may lose a significant portion, or all, of the principal amount
■ Your return on the Securities will depend solely on the performance of the Underlying that is the Lowest Performing Underlying on each Call Date. You will not benefit in any way from the performance of the better performing Underlyings. Therefore, you will be adversely affected if any Underlying performs poorly, even if the other Underlyings perform favorably
■ Any positive return on the Securities will be limited to the applicable Call Premium, even if the closing value of the Lowest Performing Underlying on the applicable Call Date significantly exceeds its Starting Value. You will not participate in any appreciation of any Underlying beyond the applicable fixed Call Premium
■ All payments on the Securities are subject to the credit risk of BofA Finance LLC ("BofA Finance"), as issuer of the Securities, and Bank of America Corporation ("BAC" or the "Guarantor"), as guarantor of the Securities
■ Securities will not be listed on any securities exchange
|
Public offering price
|
Underwriting Discount(1)(2)
|
Proceeds, before expenses, to BofA Finance
|
|
Per Security
|
$1,000.00
|
$25.75
|
$974.25
|
Total
|
$1,507,000.00
|
$38,805.25
|
$1,468,194.75
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Terms of the Securities
|
Issuer:
|
BofA Finance LLC.
|
||
Guarantor:
|
BAC.
|
||
Underlyings:
|
The Nasdaq-100® Index (Bloomberg symbol: "NDX"), a price return index, the SPDR® S&P® Biotech ETF (Bloomberg symbol: "XBI"), an exchange-traded fund, and the SPDR® S&P® Oil & Gas Exploration & Production ETF (Bloomberg symbol: "XOP"), an exchange-traded fund. The Nasdaq-100® Index is sometimes referred to herein as the "Index." The SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF are sometimes collectively referred to herein as the "Funds."
|
||
Pricing Date:
|
September 19, 2025.
|
||
Issue Date:
|
September 24, 2025.
|
||
Maturity Date:
|
September 24, 2029, subject to postponement as described below in "-Market Disruption Events and Postponement Provisions". The Securities are not subject to repayment at the option of any holder of the Securities prior to the Maturity Date.
|
||
Denominations:
|
$1,000 and any integral multiple of $1,000. References in this pricing supplement to a "Security" are to a Security with a principal amount of $1,000.
|
||
Automatic Call:
|
If the closing value of the Lowest Performing Underlying on any Call Date is greater than or equal to its Call Value, the Securities will be automatically called, and on the related Call Settlement Date you will be entitled to receive a cash payment per Security in U.S. dollars equal to the principal amount per Security plus the Call Premium applicable to the relevant Call Date. The last Call Date is the Final Calculation Day, and payment upon an automatic call on the Final Calculation Day, if applicable, will be made on the Maturity Date.
Any positive return on the Securities will be limited to the applicable Call Premium, even if the closing value of the Lowest Performing Underlying on the applicable Call Date significantly exceeds its Call Value. You will not participate in any appreciation of any Underlying beyond the applicable Call Premium.
If the Securities are automatically called, they will cease to be outstanding on the related Call Settlement Date and you will have no further rights under the Securities after such Call Settlement Date. You will not receive any notice from us if the Securities are automatically called.
|
||
Call Dates and Call Premiums:
|
The Call Premium applicable to each Call Date is a percentage of the principal amount that increases for each Call Date based on a simple (non-compounding) return of approximately 12.00% per annum.
The actual Call Premium and payment per Security upon an automatic call that are applicable to each Call Date are specified in the table below.
Call Date
Call Premium
Payment per Security upon an Automatic Call
September 24, 2026
12.00% of the principal amount
$1,120.00
October 26, 2026
13.00% of the principal amount
$1,130.00
November 24, 2026
14.00% of the principal amount
$1,140.00
December 24, 2026
15.00% of the principal amount
$1,150.00
January 25, 2027
16.00% of the principal amount
$1,160.00
February 24, 2027
17.00% of the principal amount
$1,170.00
March 24, 2027
18.00% of the principal amount
$1,180.00
April 26, 2027
19.00% of the principal amount
$1,190.00
May 24, 2027
20.00% of the principal amount
$1,200.00
June 24, 2027
21.00% of the principal amount
$1,210.00
July 26, 2027
22.00% of the principal amount
$1,220.00
August 24, 2027
23.00% of the principal amount
$1,230.00
September 24, 2027
24.00% of the principal amount
$1,240.00
October 25, 2027
25.00% of the principal amount
$1,250.00
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
November 24, 2027
26.00% of the principal amount
$1,260.00
December 27, 2027
27.00% of the principal amount
$1,270.00
January 24, 2028
28.00% of the principal amount
$1,280.00
February 24, 2028
29.00% of the principal amount
$1,290.00
March 24, 2028
30.00% of the principal amount
$1,300.00
April 24, 2028
31.00% of the principal amount
$1,310.00
May 24, 2028
32.00% of the principal amount
$1,320.00
June 26, 2028
33.00% of the principal amount
$1,330.00
July 24, 2028
34.00% of the principal amount
$1,340.00
August 24, 2028
35.00% of the principal amount
$1,350.00
September 25, 2028
36.00% of the principal amount
$1,360.00
October 24, 2028
37.00% of the principal amount
$1,370.00
November 24, 2028
38.00% of the principal amount
$1,380.00
December 26, 2028
39.00% of the principal amount
$1,390.00
January 24, 2029
40.00% of the principal amount
$1,400.00
February 26, 2029
41.00% of the principal amount
$1,410.00
March 26, 2029
42.00% of the principal amount
$1,420.00
April 24, 2029
43.00% of the principal amount
$1,430.00
May 24, 2029
44.00% of the principal amount
$1,440.00
June 25, 2029
45.00% of the principal amount
$1,450.00
July 24, 2029
46.00% of the principal amount
$1,460.00
August 24, 2029
47.00% of the principal amount
$1,470.00
September 19, 2029
48.00% of the principal amount
$1,480.00
We refer to September 19, 2029 as the "Final Calculation Day."
The Call Dates are subject to postponement as described below in "-Market Disruption Events and Postponement Provisions".
|
|||
Call Settlement Date:
|
Three business days after the applicable Call Date (as each such Call Date may be postponed as described below in "-Market Disruption Events and Postponement Provisions", if applicable); provided that the Call Settlement Date for the last Call Date is the Maturity Date.
|
||
Maturity Payment Amount:
|
If the Securities are not automatically called, you will be entitled to receive on the Maturity Date a cash payment per Security in U.S. dollars equal to the Maturity Payment Amount. The "Maturity Payment Amount" per Security will equal:
• if the Ending Value of the Lowest Performing Underlying on the Final Calculation Day is less than its Call Value but greater than or equal to its Threshold Value:
$1,000; or
• if the Ending Value of the Lowest Performing Underlying on the Final Calculation Day is less than its Threshold Value:
$1,000 × Performance Factor of the Lowest Performing Underlying on the Final Calculation Day
If the Securities are not automatically called and the Ending Value of the Lowest Performing Underlying on the Final Calculation Day is less than its Threshold Value, you will lose more than 40%, and possibly all, of the principal amount of your Securities on the Maturity Date.
|
||
Lowest Performing Underlying:
|
For any Call Date, the "Lowest Performing Underlying" will be the Underlying with the lowest Performance Factor on that Call Date.
|
||
Performance Factor:
|
With respect to an Underlying on any Call Date, its closing value on such Call Date divided by its Starting Value (expressed as a percentage).
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
•
|
Product Supplement No. WF-1 dated March 8, 2023:
|
•
|
Series A MTN prospectus supplement dated December 30, 2022 and prospectus dated December 30, 2022: https://www.sec.gov/Archives/edgar/data/1682472/000119312522315195/d409418d424b3.htm
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Investor Considerations
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Determining Timing and Amount of Payment on the Securities
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Selected Risk Considerations
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
●
|
Changes that affect the Index may adversely affect the value of the Securities and any payments on the Securities.
|
●
|
We cannot control actions by any of the unaffiliated companies whose securities are included in the Index.
|
●
|
We and our affiliates have no affiliation with the index sponsor and have not independently verified its public disclosure of information.
|
●
|
Risks associated with a fund underlying index, or the underlying assets of a Fund, will affect the value of that Fund and hence the value of the Securities.
|
●
|
Changes that affect a Fund or its fund underlying index may adversely affect the value of the Securities and any payments on the Securities.
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
●
|
We cannot control actions by any of the unaffiliated companies whose securities are held by or included in a Fund or its fund underlying index.
|
●
|
We and our affiliates have no affiliation with any fund sponsor or fund underlying index sponsor and have not independently verified their public disclosure of information.
|
●
|
There are risks associated with funds.
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Hypothetical Examples and Returns
|
Call Premiums:
|
12.00% for the first Call Date, 13.00% for the second Call Date, 14.00% for the third Call Date, 15.000% for the fourth Call Date, 16.00% for the fifth Call Date, 17.00% for the sixth Call Date, 18.00% for the seventh Call Date, 19.00% for the eighth Call Date, 20.00% for the ninth Call Date, 21.00% for the tenth Call Date, 22.00% for the eleventh Call Date, 23.00% for the twelfth Call Date, 24.00% for the thirteenth Call Date, 25.00% for the fourteenth Call Date, 26.00% for the fifteenth Call Date, 27.00% for the sixteenth Call Date, 28.00% for the seventeenth Call Date, 29.00% for the eighteenth Call Date, 30.00% for the nineteenth Call Date, 31.00% for the twentieth Call Date, 32.00% for the twenty-first Call Date, 33.00% for the twenty-second Call Date, 34.00% for the twenty-third Call Date, 35.00% for the twenty-fourth Call Date, 36.00% for the twenty-fifth Call Date, 37.00% for the twenty-sixth Call Date, 38.00% for the twenty-seventh Call Date, 39.00% for the twenty-eighth Call Date, 40.00% for the twenty-ninth Call Date, 41.00% for the thirtieth Call Date, 42.00% for the thirty-first Call Date, 43.00% for the thirty-second Call Date, 44.00% for the thirty-third Call Date, 45.00% for the thirty-fourth Call Date, 46.00% for the thirty-fifth Call Date, 47.00% for the thirty-sixth Call Date and 48.00% for the thirty-seventh Call Date
|
Hypothetical Starting Value:
|
For each Underlying, 100.00
|
Hypothetical Call Value:
|
For each Underlying, 86.00 (86% of its hypothetical Starting Value)
|
Hypothetical Threshold Value:
|
For each Underlying, 60.00 (60% of its hypothetical Starting Value)
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Hypothetical Call Date on which Securities are automatically called
|
Hypothetical payment per Security on related Call Settlement Date
|
Hypothetical pre-tax total rate of return
|
1st Call Date
|
$1,120.00
|
12.00%
|
2nd Call Date
|
$1,130.00
|
13.00%
|
3rd Call Date
|
$1,140.00
|
14.00%
|
4th Call Date
|
$1,150.00
|
15.00%
|
5th Call Date
|
$1,160.00
|
16.00%
|
6th Call Date
|
$1,170.00
|
17.00%
|
7th Call Date
|
$1,180.00
|
18.00%
|
8th Call Date
|
$1,190.00
|
19.00%
|
9th Call Date
|
$1,200.00
|
20.00%
|
10th Call Date
|
$1,210.00
|
21.00%
|
11th Call Date
|
$1,220.00
|
22.00%
|
12th Call Date
|
$1,230.00
|
23.00%
|
13th Call Date
|
$1,240.00
|
24.00%
|
14th Call Date
|
$1,250.00
|
25.00%
|
15th Call Date
|
$1,260.00
|
26.00%
|
16th Call Date
|
$1,270.00
|
27.00%
|
17th Call Date
|
$1,280.00
|
28.00%
|
18th Call Date
|
$1,290.00
|
29.00%
|
19th Call Date
|
$1,300.00
|
30.00%
|
20th Call Date
|
$1,310.00
|
31.00%
|
21st Call Date
|
$1,320.00
|
32.00%
|
22nd Call Date
|
$1,330.00
|
33.00%
|
23rd Call Date
|
$1,340.00
|
34.00%
|
24th Call Date
|
$1,350.00
|
35.00%
|
25th Call Date
|
$1,360.00
|
36.00%
|
26th Call Date
|
$1,370.00
|
37.00%
|
27th Call Date
|
$1,380.00
|
38.00%
|
28th Call Date
|
$1,390.00
|
39.00%
|
29th Call Date
|
$1,400.00
|
40.00%
|
30th Call Date
|
$1,410.00
|
41.00%
|
31st Call Date
|
$1,420.00
|
42.00%
|
32nd Call Date
|
$1,430.00
|
43.00%
|
33rd Call Date
|
$1,440.00
|
44.00%
|
34th Call Date
|
$1,450.00
|
45.00%
|
35th Call Date
|
$1,460.00
|
46.00%
|
36th Call Date
|
$1,470.00
|
47.00%
|
37th Call Date
|
$1,480.00
|
48.00%
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Hypothetical Performance Factor of the Lowest Performing Underlying on the Final Calculation Day(1)
|
Hypothetical Maturity Payment Amount per Security
|
Hypothetical pre-tax total rate of return
|
85.00%
|
$1,000.00
|
0.00%
|
80.00%
|
$1,000.00
|
0.00%
|
60.00%
|
$1,000.00
|
0.00%
|
59.00%
|
$590.00
|
-41.00%
|
50.00%
|
$500.00
|
-50.00%
|
25.00%
|
$250.00
|
-75.00%
|
0.00%
|
$0.00
|
-100.00%
|
Nasdaq-100® Index
|
SPDR® S&P® Biotech ETF
|
SPDR® S&P® Oil & Gas Exploration & Production ETF
|
|||
Hypothetical Starting Value:
|
100.00
|
$100.00
|
$100.00
|
||
Hypothetical Call Value:
|
86.00
|
$86.00
|
$86.00
|
||
Hypothetical closing value on first Call Date:
|
140.00
|
$135.00
|
$130.00
|
||
Performance Factor on first Call Date (closing value on first Call Datedivided by Starting Value):
|
140.00%
|
135.00%
|
130.00%
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Nasdaq-100® Index
|
SPDR® S&P® Biotech ETF
|
SPDR® S&P® Oil & Gas Exploration & Production ETF
|
|
Hypothetical Starting Value:
|
100.00
|
$100.00
|
$100.00
|
Hypothetical Call Value:
|
86.00
|
$86.00
|
$86.00
|
Hypothetical closing values on Call Dates prior to the Final Calculation Day:
|
Various (all below Call Value)
|
Various (all above Call Value)
|
Various (all below Call Value)
|
Hypothetical closing value on Final Calculation Day (i.e., the Ending Value):
|
110.00
|
107.00
|
99.00
|
Performance Factor on Final Calculation Day (Ending Value divided by Starting Value):
|
110.00%
|
107.00%
|
99.00%
|
Nasdaq-100® Index
|
SPDR® S&P® Biotech ETF
|
SPDR® S&P® Oil & Gas Exploration & Production ETF
|
|
Hypothetical Starting Value:
|
100.00
|
$100.00
|
$100.00
|
Hypothetical Call Value:
|
86.00
|
$86.00
|
$86.00
|
Hypothetical closing values on Call Dates prior to the Final Calculation Day:
|
Various (all below Call Value)
|
Various (all below Call Value)
|
Various (all below Call Value)
|
Hypothetical Ending Value:
|
115.00
|
$110.00
|
$85.00
|
Hypothetical Threshold Value:
|
60.00
|
$60.00
|
$60.00
|
Performance Factor on Final Calculation Day (Ending Valuedivided by Starting Value):
|
115.00%
|
110.00%
|
85.00%
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Nasdaq-100® Index
|
SPDR® S&P® Biotech ETF
|
SPDR® S&P® Oil & Gas Exploration & Production ETF
|
|
Hypothetical Starting Value:
|
100.00
|
$100.00
|
$100.00
|
Hypothetical closing values on Call Dates prior to the Final Calculation Day:
|
Various (all below Call Value)
|
Various (all above Call Value)
|
Various (all above Call Value)
|
Hypothetical Ending Value:
|
50.00
|
$110.00
|
$120.00
|
Hypothetical Threshold Value:
|
60.00
|
$60.00
|
$60.00
|
Performance Factor on Final Calculation Day (Ending Valuedivided by Starting Value):
|
50.00%
|
110.00%
|
120.00%
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
All disclosures contained in this pricing supplement regarding the Underlyings, including, without limitation, their make-up, method of calculation, and changes in their components, have been derived from publicly available sources. The information reflects the policies of, and is subject to change by, each of Nasdaq, Inc., the sponsor of the NDX, and SSGA Funds Management, Inc. ("SSGA"), the investment advisor to each of the XBI and the XOP. We refer to SSGA as the "Investment Advisor" and Nasdaq, Inc. as the "Underlying Sponsor". The Investment Advisor and the Underlying Sponsor, which license the copyright and all other rights to the respective Underlyings, have no obligation to continue to publish, and may discontinue publication of, the Underlyings. The consequences of the Underlying Sponsor or Investment Advisor discontinuing publication of the applicable Underlying are discussed in "General Terms of the Securities - Discontinuance of an Index" and "-Anti-dilution Adjustments Relating to a Fund; Alternate Calculation" in the accompanying product supplement. None of us, the Guarantor, the calculation agent, or BofAS accepts any responsibility for the calculation, maintenance or publication of any Underlying or any successor index or successor fund. None of us, the Guarantor, BofAS or any of our other affiliates makes any representation to you as to the future performance of the Underlyings. You should make your own investigation into the Underlyings.
|
The Nasdaq-100® Index
|
●
|
the security's U.S. listing must be exclusively on the Nasdaq Global Select Market or the Nasdaq Global Market (unless the security was dually listed on another U.S. market prior to January 1, 2004 and has continuously maintained such listing);
|
●
|
the security must be of a non-financial company;
|
●
|
the security may not be issued by an issuer currently in bankruptcy proceedings;
|
●
|
the security must have a minimum three-month average daily trading volume of at least 200,000 shares;
|
●
|
if the issuer of the security is organized under the laws of a jurisdiction outside the U.S., then such security must have listed options on a recognized options market in the U.S. or be eligible for listed-options trading on a recognized options market in the U.S.;
|
●
|
the issuer of the security may not have entered into a definitive agreement or other arrangement which would likely result in the security no longer being eligible for inclusion in the NDX;
|
●
|
the issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn; and
|
●
|
the issuer of the security must have "seasoned" on NASDAQ, the New York Stock Exchange or NYSE Amex. Generally, a company is considered to be seasoned if it has been listed on a market for at least three full months (excluding the first month of initial listing).
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
●
|
the security's U.S. listing must be exclusively on the Nasdaq Global Select Market or the Nasdaq Global Market;
|
●
|
the security must be of a non-financial company;
|
●
|
the security may not be issued by an issuer currently in bankruptcy proceedings;
|
●
|
the security must have a minimum three-month average daily trading volume of at least 200,000 shares;
|
●
|
if the issuer of the security is organized under the laws of a jurisdiction outside the U.S., then such security must have listed options on a recognized options market in the U.S. or be eligible for listed-options trading on a recognized options market in the U.S. (measured annually during the ranking review process);
|
●
|
the security must have an adjusted market capitalization equal to or exceeding 0.10% of the aggregate adjusted market capitalization of the NDX at each month-end. In the event a company does not meet this criterion for two consecutive month-ends, it will be removed from the NDX effective after the close of trading on the third Friday of the following month; and
|
●
|
the issuer of the security may not have annual financial statements with an audit opinion that is currently withdrawn.
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
The SPDR® S&P® Biotech ETF
|
●
|
float-adjusted market capitalization above US$500 million and float-adjusted liquidity ratio above 90%; or
|
●
|
float-adjusted market capitalization above US$400 million and float-adjusted liquidity ratio above 150%.
|
●
|
Market Capitalization: Float-adjusted market capitalization should be at least US$400 million for inclusion in the underlying index. Existing index components must have a float-adjusted market capitalization of US$300 million to remain in the underlying index at each rebalancing.
|
●
|
Liquidity: The liquidity measurement used is a liquidity ratio, defined as dollar value traded over the previous 12-months divided by the float-adjusted market capitalization as of the underlying index rebalancing reference date. Stocks having a float-adjusted market capitalization above US$500 million must have a liquidity ratio greater than 90% to be eligible for addition to the underlying index. Stocks having a float-adjusted market capitalization between US$400 and US$500 million must have a liquidity ratio greater than 150% to be eligible for addition to the underlying index. Existing index constituents must have a liquidity ratio greater than 50% to remain in the underlying index at the quarterly rebalancing. The length of time to evaluate liquidity is reduced to the available trading period for IPOs or spin-offs that do not have 12 months of trading history.
|
●
|
Takeover Restrictions: At the discretion of S&P, constituents with shareholder ownership restrictions defined in company bylaws may be deemed ineligible for inclusion in the underlying index. Ownership restrictions preventing entities from replicating the index weight of a company may be excluded from the eligible universe or removed from the underlying index.
|
●
|
Turnover: S&P believes turnover in index membership should be avoided when possible. At times, a company may appear to temporarily violate one or more of the addition criteria. However, the addition criteria are for addition to the underlying index, not for continued membership. As a result, an index constituent that appears to violate the criteria for addition to the underlying index will not be deleted unless ongoing conditions warrant a change in the composition of the underlying index.
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
The SPDR® S&P® Oil & Gas Exploration & Production ETF
|
●
|
float-adjusted market capitalization above US$500 million and float-adjusted liquidity ratio above 90%; or
|
●
|
float-adjusted market capitalization above US$400 million and float-adjusted liquidity ratio above 150%.
|
●
|
Market Capitalization: Float-adjusted market capitalization should be at least US$400 million for inclusion in the underlying index. Existing index components must have a float-adjusted market capitalization of US$300 million to remain in the underlying index at each rebalancing.
|
●
|
Liquidity: The liquidity measurement used is a liquidity ratio, defined as dollar value traded over the previous 12 months divided by the float-adjusted market capitalization as of the underlying index rebalancing reference date. Stocks having a float-adjusted market capitalization above US$500 million must have a liquidity ratio greater than 90% to be eligible for addition to the underlying index. Stocks having a float-adjusted market capitalization between US$400 and US$500 million must have a liquidity ratio greater than 150% to be eligible for addition to the underlying index. Existing index constituents must have a liquidity ratio greater than 50% to remain in the underlying index at the quarterly rebalancing. The length of time to evaluate liquidity is reduced to the available trading period for IPOs or spin-offs that do not have 12 months of trading history.
|
●
|
Takeover Restrictions: At the discretion of S&P, constituents with shareholder ownership restrictions defined in company bylaws may be deemed ineligible for inclusion in the underlying index. Ownership restrictions preventing entities from replicating the index weight of a company may be excluded from the eligible universe or removed from the underlying index.
|
●
|
Turnover: S&P believes turnover in index membership should be avoided when possible. At times a company may appear to temporarily violate one or more of the addition criteria. However, the addition criteria are for addition to the underlying index, not for continued membership. As a result, an index constituent that appears to violate the criteria for addition to the underlying index will not be deleted unless ongoing conditions warrant a change in the composition of the underlying index.
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
Structuring the Securities
|
Validity of the Securities
|
Market Linked Securities-Auto-Callable with Contingent Downside
Principal at Risk Securities Linked to the Lowest Performing of the Nasdaq-100® Index, the SPDR® S&P® Biotech ETF and the SPDR® S&P® Oil & Gas Exploration & Production ETF due September 24, 2029
|
U.S. Federal Income Tax Summary
|
•
|
There is no statutory, judicial, or administrative authority directly addressing the characterization of the Securities.
|
•
|
You agree with us (in the absence of an administrative determination, or judicial ruling to the contrary) to characterize and treat the Securities for all tax purposes as single financial contracts with respect to the Underlyings. In the opinion of Sidley Austin LLP, our tax counsel, the U.S. federal income tax characterization and treatment of the Securities described herein is a reasonable interpretation of current law.
|
•
|
Under this characterization and tax treatment of the Securities, a U.S. Holder (as defined on page 71 of the accompanying prospectus) generally will recognize capital gain or loss upon maturity or upon a sale, exchange or redemption of the Securities. This capital gain or loss generally will be long-term capital gain or loss if you held the Securities for more than one year.
|
•
|
No assurance can be given that the Internal Revenue Service ("IRS") or any court will agree with this characterization and tax treatment.
|
•
|
Under current IRS guidance, withholding on "dividend equivalent" payments (as discussed in the accompanying product supplement), if any, will not apply to Securities that are issued as of the date of this pricing supplement unless such Securities are "delta-one" instruments. Based on our determination that the Securities are not delta-one instruments, Non-U.S. Holders should not be subject to withholding on dividend equivalent payments, if any, under the Securities.
|
•
|
Under current law, while the matter is not entirely clear, individual Non-U.S. Holders, and entities whose property is potentially includible in those individuals' gross estates for U.S. federal estate tax purposes (for example, a trust funded by such an individual and with respect to which the individual has retained certain interests or powers), should note that, absent an applicable treaty benefit, the Securities are likely to be treated as U.S. situs property, subject to U.S. federal estate tax. These individuals and entities should consult their own tax advisors regarding the U.S. federal estate tax consequences of investing in the Securities.
|